Vicki L. Goodman - Feb 15, 2023 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Role
EVP, Prod Dev & Med Aff &CMO
Signature
/s/ Nina Ayer, Attorney in Fact
Stock symbol
EXEL
Transactions as of
Feb 15, 2023
Transactions value $
-$312,766
Form type
4
Date filed
2/17/2023, 08:38 PM
Previous filing
Jan 6, 2022
Next filing
Apr 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Tax liability -$313K -17.3K -7.14% $18.08 225K Feb 15, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Exelixis, Inc. to satisfy taxes payable in connection with the vesting of restricted stock units awarded January 4, 2022.
F2 Includes 163,817 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.